CAM
TNDM icon

ClariVest Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

ClariVest Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.13M Hold
28,149
– – 0.12% 241
2024
Q2 		$1.13M Buy
+28,149
New +$1.17M 0.12% 241
2020
Q1 		– Sell
-30,532
Closed -$1.82M – 774
2019
Q4 		$1.82M Sell
30,532
-20,437
-40% -$1.26M 0.04% 256
2019
Q3 		$3.01M Sell
50,969
-600
-1% -$38.3K 0.07% 208
2019
Q2 		$3.33M Sell
51,569
-500
-1% -$32.3K 0.08% 202
2019
Q1 		$3.31M Sell
52,069
-19,469
-27% -$1.02M 0.07% 235
2018
Q4 		$2.72M Buy
71,538
+34,421
+93% +$1.22M 0.06% 254
2018
Q3 		$1.59M Buy
+37,117
New +$1.3M 0.03% 358

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return